Percentage of patients aged 18 years and older with a diagnosis of chronic hepatitis C who were prescribed at a minimum peginterferon and ribavirin therapy within the 12 month reporting period
- Measure TypeElectronic Clinical Quality Measure (eCQM)Level Of AnalysisCare SettingNumerator
Patients who were prescribed at a minimum peginterferon and ribavirin therapy within the 12 month reporting period
DenominatorAll patients aged 18 years and older with a diagnosis of chronic hepatitis C
ExclusionsDocumentation of medical reason(s) why a patient was not prescribed at a minimum peginterferon and ribavirin therapy (eg, patient was not a candidate for therapy, could not tolerate)
Documentation of patient reason(s) why a patient was not prescribed at a minimum peginterferon and ribavirin therapy (eg, patient declined)
Documentation of system reason(s) why a patient was not prescribed at a minimum peginterferon and ribavirin therapy (eg, patient has no insurance coverage, therapy not covered)Testing Data Sources
- Measure StructureClinical Condition Topic AreaTarget PopulationNational Quality Strategy PrioritiesHealth and Well-Being
- Risk Adjustment
- Current or planned use(s)
- Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Infectious Disease Endorsement Maintenance ProjectInitial EndorsementEndorsement StatusLast UpdatedRemoval Date
- Steward Organization EmailSteward Organization Copyright
Physician Performance Measures (Measures) and related data specifications have been developed by the American Medical Association (AMA)-convened Physician Consortium for Performance Improvement® (PCPI™).
These performance Measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications.
The Measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, e.g., use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the Measures require a license agreement between the user and the AMA (on behalf of the PCPI). Neither the AMA, PCPI nor its members shall be responsible for any use of the Measures.
THE MEASURES AND SPECIFICATIONS ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND
© 2012 American Medical Association. All Rights Reserved.
Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AMA, the PCPI and its members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT®) or other coding contained in the specifications.
CPT® contained in the Measure specifications is copyright 2004- 2011 American Medical Association.
LOINC® copyright 2004-2010 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms® (SNOMED CT®)copyright 2004-2010 International Health Terminology Standards Development Organisation. All Rights Reserved.